Carbapenem Resistance Revisited: Reassessing Our Antibiotics of Choice
Join Marin H. Kollef, MD in the first of 3 recap podcasts taken from our live event, “The Plot (and Sputum) Thickens: Encountering Carbapenem Resistance in Critically Ill Patients” to learn how to optimize antimicrobial regimens and develop evidence-based antibiotic management plans for complex infections caused by carbapenem-resistant bacteria. This episode covers reassessment of carbapenemases and antibiotic selection.
Decera Clinical Education Infectious Disease Podcast · Marin H. Kollef MD
Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Join Marin H. Kollef, MD in the first of 3 podcasts from our live event, “The Plot (and Sputum) Thickens: Encountering Carbapenem Resistance in Critically Ill Patients” to learn how to optimize antimicrobial regimens and develop evidence-based antibiotic management plans for complex infections caused by carbapenem-resistant bacteria. Topics covered in this segment include
- Antimicrobial resistance mechanisms
- Diagnostic strategies for identifying resistance
- Antibiotic selection strategies
- Preferred and alternative antibiotics according to guideline recommendations
Presenter:
Marin H. Kollef, MD
Virginia E. and Sam J. Golman Chair in Respiratory Intensive Care Medicine
Professor of Medicine
Division of Pulmonary & Critical Care Medicine
Director, Critical Care Research
Director, Respiratory Care Services
Washington University School of Medicine
St Louis, Missouri
Link to full program and downloadable slides:
ProCE:
https://bit.ly/4pA1Xm4
Get access to all of our new podcasts by subscribing to the Decera Clinical Education Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.